Brian comes to DRI with more than 20 years of leadership and management experience in the life sciences private sector, where he focused on scaling up research focused ventures, translating innovation into competitive products and visioning new market opportunities. He served in a diverse array of roles focused on product and business development to include Director of Clinical Research and Business Development for Vela Pharmaceuticals, global portfolio director for the neuroscience portfolio at Eisai Medical Research, and was part of the founding management teams of both Krele Pharmaceuticals, Inc. and TONIX Pharmaceuticals (NASDAQ:TNXP). Most recently, he was Vice President for Corporate Development with PHARMOS Corporation and LIM Advisors.